Mallen, Adrianne R.
Conley, Claire C. http://orcid.org/0000-0001-7695-2428
Fuzzell, Lindsay
Ketcher, Dana
Augusto, Bianca M.
McIntyre, McKenzie
Barton, Laura V.
Townsend, Mary K.
Fridley, Brooke L.
Tworoger, Shelley S.
Wenham, Robert M.
Vadaparampil, Susan T.
Funding for this research was provided by:
Miles for Moffitt (N/A)
National Cancer Institute (T32CA090314, P30CA076292)
Article History
Received: 7 May 2020
Accepted: 11 September 2020
First Online: 25 September 2020
Compliance with ethical standards
:
: Dr. Wenham has participated in data safety monitoring, trial steering, advisory, and speaker activities for which he has received honoraria from Tesaro, Clovis, Genentech, Mersana, Marker Therapeutics, Ovation Diagnostics, AstraZeneca, and Merck. He is also a principal investigator for a number of sponsored clinical trials. Ms. Barton has participated in advisory activities for which she has received honoraria from AstraZeneca and Merck. No other authors have conflicts of interest to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. All procedures were approved by the Institutional Review Board at the University of South Florida (Protocol #00035939).
: Written informed consent was obtained from all individual participants included in the study.